CoreCap Advisors’s CareDx CDNA Stock Holding History

CoreCap Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14	Closed	-$248	–	2843
2025 Q1	$248	Buy	+14	New	+$302	﹤0.01%	2879

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

CoreCap Advisors's CDNA Position: Q2 2025 in Review

CoreCap Advisors sold out of CareDx (CDNA) in Q2 2025, closing a stake of 14 shares — an estimated $248 sold.

CoreCap Advisors first reported a position in CDNA in Q1 2025 and held it in 1 quarter. The position peaked at $248 in Q1 2025. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

CoreCap Advisors reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
CoreCap Advisors sold 14 CareDx shares in Q2 2025, an estimated $248.
CoreCap Advisors first reported a position in CareDx in Q1 2025 and held it in 1 quarter.
CoreCap Advisors's CareDx position peaked at $248 in Q1 2025.
197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.